Prognostic value of left atrial strain in patients with moderate asymptomatic mitral regurgitation.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 23 01 2019
accepted: 03 04 2019
pubmed: 12 4 2019
medline: 3 9 2019
entrez: 12 4 2019
Statut: ppublish

Résumé

For patients with asymptomatic mitral regurgitation (MR), the criteria identifying the groups at higher-risk and their clinical outcome are still uncertain. Therefore, in these patients, optimal time of surgery remains controversial. The purpose of this study was to compare left atrial (LA) strain to other echocardiographic left ventricular (LV) and LA parameters for the prediction of cardiovascular outcomes in patients with moderate asymptomatic MR. We enrolled 395 patients with primary degenerative moderate asymptomatic MR. Exclusion criteria were: history of atrial fibrillation, myocardial infarction, heart failure, cardiac surgery or heart transplantation, severe MR, mitral valve surgery during follow-up. Patients were prospectively followed for 3.5 ± 1.6 years for the development of cardiovascular events i.e. atrial fibrillation, stroke/transient ischaemic attack, acute heart failure, cardiovascular death. Of 276 patients (mean age 66 ± 8 years) who met eligibility criteria, 108 patients had 141 new events. Patients who developed cardiovascular events presented reduced global peak atrial longitudinal strain (PALS), reduced LA emptying fraction, larger LA volume indexed and lower LV strain at baseline (p < 0.0001). With receiving operating characteristics (ROC) curve analysis, global PALS < 35% showed the greatest predictive performance (AUC global PALS: 0.87). Bland-Altman analysis demonstrated good intra- and interobserver agreement with small bias and Kaplan-Meier analysis showed a graded association between PALS and event-free-survival rates. Speckle tracking imaging could provide a useful index, global PALS, to estimate LA function in asymptomatic moderate MR in order to optimize timing of surgery before the development of irreversible myocardial dysfunction.

Identifiants

pubmed: 30972528
doi: 10.1007/s10554-019-01598-6
pii: 10.1007/s10554-019-01598-6
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1597-1604

Références

Circulation. 2000 Oct 10;102(15):1788-94
pubmed: 11023933
J Am Soc Echocardiogr. 2002 Feb;15(2):167-84
pubmed: 11836492
Circulation. 1963 Jan;27:29-35
pubmed: 14015085
J Heart Valve Dis. 2004 Jan;13(1):27-32
pubmed: 14765836
Cardiovasc Res. 2005 Sep 1;67(4):655-66
pubmed: 15913581
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
J Am Soc Echocardiogr. 2006 Sep;19(9):1085-91
pubmed: 16950462
J Am Coll Cardiol. 2007 May 15;49(19):1903-14
pubmed: 17498573
Eur Heart J. 2007 Nov;28(21):2627-36
pubmed: 17526904
Circulation. 2007 Aug 7;116(6):637-47
pubmed: 17646587
J Am Coll Cardiol. 2010 Aug 10;56(7):570-8
pubmed: 20688212
Echocardiography. 2011 Mar;28(3):327-34
pubmed: 21323986
Eur J Echocardiogr. 2011 Apr;12(4):291-8
pubmed: 21343164
Eur J Echocardiogr. 2011 May;12(5):384-93
pubmed: 21447498
Int J Cardiovasc Imaging. 2012 Oct;28(7):1663-70
pubmed: 22130899
Cardiovasc Ultrasound. 2012 Feb 01;10:4
pubmed: 22296702
Am J Cardiol. 2013 Feb 15;111(4):595-601
pubmed: 23211360
Echocardiography. 2015 Jul;32(7):1122-30
pubmed: 25327943
Conn Med. 2015 Sep;79(8):469-75
pubmed: 26506678
Int J Cardiol. 2017 Jan 15;227:106-113
pubmed: 27855288
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):591-600
pubmed: 29596561
J Med Ultrasound. 2017 Jan-Mar;25(1):16-23
pubmed: 30065450
N Engl J Med. 1996 Nov 7;335(19):1417-23
pubmed: 8875918

Auteurs

Matteo Cameli (M)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Maria Concetta Pastore (MC)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy. pastore2411@gmail.com.

Francesca Maria Righini (FM)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Giulia Elena Mandoli (GE)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Flavio D'Ascenzi (F)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Matteo Lisi (M)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Dan Nistor (D)

Department M3, University of Medicine and Pharmacy Targu Mures, Targu Mures, Romania.

Stefania Sparla (S)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Valeria Curci (V)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Cristina Di Tommaso (C)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Francesco Marino (F)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Mario Stricagnoli (M)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Sergio Mondillo (S)

Department of Cardiovascular Diseases, University of Siena, Viale Bracci 1, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH